Finance

Lists
Why is 600664 up ၂.၁၀%?
Dive Deeper
600664:SHA
Harbin Pharmaceutical Group Co Ltd
၆.၃၂ CN¥
+၂.၁၀%
(+၀.၁၃) 1D
အောက် ၁၆, GMT+၈ ၁၅:၀၀:၀၁  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 600664...
Open
၆.၂၆ CN¥
High
၆.၇၇ CN¥
Low
၆.၁၉ CN¥
Mkt. cap
ဋေ ၁.၅၉ ထ
Avg. vol.
၃၈.၇၁ ကုဋေ
Volume
၄၁.၂၄ ကုဋေ
P/E ratio
၃၁.၀၈
52-wk high
၉.၈၆ CN¥
52-wk low
၂.၈၄ CN¥
EPS
၀.၂၀ CN¥
Shares outstanding
၂၅၄.၅၀ ဋေ
No. of employees
၁ သောင်း
Open
၆.၂၆ CN¥
High
၆.၇၇ CN¥
Low
၆.၁၉ CN¥
Mkt. cap
ဋေ ၁.၅၉ ထ
Avg. vol.
၃၈.၇၁ ကုဋေ
Volume
၄၁.၂၄ ကုဋေ
P/E ratio
၃၁.၀၈
52-wk high
၉.၈၆ CN¥
52-wk low
၂.၈၄ CN¥
EPS
၀.၂၀ CN¥
Shares outstanding
၂၅၄.၅၀ ဋေ
No. of employees
၁ သောင်း
News stories
From web sources and news partners
The Motley Fool
The Motley Fool
·
ပြီးခဲ့သည့် ၂၁ မိနစ်
Moderna Just Joined the Nasdaq-100. Here's What That Means for Investors.
Simply Wall Street
Simply Wall Street
·
ပြီးခဲ့သည့် ၁ နာရီ
Is INmune Bio (NASDAQ:INMB) In A Good Position To Deliver On Growth Plans?
Profile
Harbin Pharmaceutical Group Co., Ltd. is a Chinese partially state-owned company engaged in the research & development, manufacture, and sale of pharmaceutical products. HPGC medication offerings include traditional Chinese medicine and biopharmaceuticals; its main offerings include antibiotics, including amoxicillin and penicillin, and dietary supplements, including zinc gluconate and calcium gluconate. The company owns both Renmintongtai, a drugstore chain and medical wholesaler for the domestic market, and GNC, a U.S.-based international retailer of supplements and wellness products. Wikipedia
About Harbin Pharmaceutical Group Co Ltd
CEO-
Employees၁ သောင်း
Founded၁၉၈၈
Headquarters-
Sector-
Websitehayao.com
Previous reportsAll values in CNY
Loading Previous Earnings...
Revenue
Net income
All values in CNY
၂၀၂၅ စက်
၂၀၂၅ ဒီ
၂၀၂၆ မတ်
၂၀၂၆ ဇွန်
Revenue
၃၈၉.၆၆ ဋေ
၃၉၄.၂၈ ဋေ
၄၁၇.၅၂ ဋေ
၄၁၂.၀၅ ဋေ
Cost of goods sold
၂၉၄.၅၇ ဋေ
၂၉၅.၇၁ ဋေ
၃၁၆.၈၇ ဋေ
၂၉၅.၉၇ ဋေ
Cost of revenue
၂၉၄.၅၇ ဋေ
၂၉၅.၇၁ ဋေ
၃၁၆.၈၇ ဋေ
၂၉၅.၉၇ ဋေ
Research and development expenses
၃.၃၆ ကုဋေ
၅.၁၃ ကုဋေ
၂.၇၀ ကုဋေ
၃.၃၄ ကုဋေ
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
၇၅.၃၅ ကုဋေ
၈၁.၆၀ ကုဋေ
၇၂.၁၂ ကုဋေ
၈၀.၃၄ ကုဋေ
Operating expense
၈၃.၈၆ ကုဋေ
၈၉.၇၀ ကုဋေ
၇၈.၆၆ ကုဋေ
၈၉.၅၉ ကုဋေ
Total operating expenses
၃၇၈.၄၃ ဋေ
၃၈၅.၄၀ ဋေ
၃၉၅.၅၃ ဋေ
၃၈၅.၅၆ ဋေ
Operating income
၁၁.၂၃ ကုဋေ
၈.၈၈ ကုဋေ
၂၁.၉၉ ကုဋေ
၂၆.၄၉ ကုဋေ
Other non operating income
၄.၆၈ သိန်း
-၁.၃၀ ကုဋေ
-၇.၉၇ သန်း
၁.၂၁ သန်း
EBT including unusual items
၁၁.၉၁ ကုဋေ
၉.၁၇ ကုဋေ
၂၀.၆၄ ကုဋေ
၃၁.၁၄ ကုဋေ
EBT excluding unusual items
၁၀.၉၉ ကုဋေ
၆.၃၇ ကုဋေ
၂၀.၈၁ ကုဋေ
၂၅.၄၃ ကုဋေ
Income tax expense
၄.၁၃ ကုဋေ
၃.၄၆ ကုဋေ
၄.၅၄ ကုဋေ
၆.၃၄ ကုဋေ
Effective tax rate
၃၄.၆၇%
၃၇.၇၅%
၂၁.၉၇%
၂၀.၃၇%
Other operating expenses
၂.၄၇ ကုဋေ
၂.၉၂ ကုဋေ
၂.၁၉ ကုဋေ
၅.၄၀ ကုဋေ
Net income
၆.၈၉ ကုဋေ
၃.၃၀ ကုဋေ
၁၆.၁၁ ကုဋေ
၂၄.၉၂ ကုဋေ
Net profit margin
၁.၇၇%
၀.၈၄%
၃.၈၆%
၆.၀၅%
Earnings per share
-
-
-
-
Interest and investment income
၄.၀၅ သန်း
၃.၁၄ သန်း
၄.၂၀ သန်း
၆.၁၂ သန်း
Interest expense
-၁.၁၁ ကုဋေ
-၁.၀၈ ကုဋေ
-၈.၀၁ သန်း
-၁.၀၁ ကုဋေ
Net interest expenses
-၇.၀၀ သန်း
-၇.၆၂ သန်း
-၃.၈၁ သန်း
-၃.၉၈ သန်း
Depreciation and amortization charges
-
-
-
-
EBITDA
၁၆.၆၄ ကုဋေ
၁၄.၃၀ ကုဋေ
၂၇.၄၂ ကုဋေ
၃၂.၀၇ ကုဋေ
Gain or loss from assets sale
၃.၉၉ သန်း
-၃.၈၃ သန်း
-
-၃.၅၈ ကုဋေ
AI content may include mistakes. Learn more
Google အက်ပ်များ